Cambrex (CBM -1%) and Dow Chemical (DOW -0.9%) sign an agreement for CBM to contract manufacture...

|About: Cambrex Corporation (CBM)|By:, SA News Editor

Cambrex (CBM -1%) and Dow Chemical (DOW -0.9%) sign an agreement for CBM to contract manufacture DOW's Hydroxypropyl Methylcellulose Acetate Succinate for use in drug solubility enhancement. The agreement is the final realization of a solubilization partnership that Dow and Bend Research announced in October 2012. Construction has already begun on the new operational facility at Cambrex Karlskoga with commercial product availability set for year-end 2013.